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P2X7 receptor activation induces reactive oxygen species formation and cell
death in murine EOC13 microglia
Abstract
The P2X7 purinergic receptor is a ligand-gated cation channel expressed on leukocytes including
microglia. This study aimed to determine if P2X7 activation induces the uptake of organic cations,
reactive oxygen species (ROS) formation, and death in the murine microglial EOC13 cell line. Using the
murine macrophage J774 cell line as a positive control, RT-PCR, immunoblotting, and immunolabelling
established the presence of P2X7 in EOC13 cells. A cytofluorometric assay demonstrated that the P2X7
agonists adenosine-5'-triphosphate (ATP) and 2' (3')-O-(4-benzoylbenzoyl) ATP induced ethidium(+) or YOPRO-1(2+) uptake into both cell lines. ATP induced ethidium+ uptake into EOC13 cells in a concentrationdependent manner, with an EC50 of similar to 130 mu M. The P2X7 antagonists Brilliant Blue G, A438079,
AZ10606120, and AZ11645373 inhibited ATP-induced cation uptake into EOC13 cells by 75-100%. A
cytofluorometric assay demonstrated that P2X7 activation induced ROS formation in EOC13 cells, via a
mechanism independent of Ca2+ influx and K+ efflux. Cytofluorometric measurements of Annexin-V
binding and 7AAD uptake demonstrated that P2X7 activation induced EOC13 cell death. The ROS
scavenger N-acetyl-L-cysteine impaired both P2X7-induced EOC13 ROS formation and cell death,
suggesting that ROS mediate P2X7-induced EOC13 death. In conclusion, P2X7 activation induces the
uptake of organic cations, ROS formation, and death in EOC13 microglia.
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e P2X7 purinergic receptor is a ligand-gated cation channel expressed on leukocytes including microglia. is study aimed
to determine if P2X7 activation induces the uptake of organic cations, reactive oxygen species (ROS) formation, and death in the
murine microglial EOC13 cell line. Using the murine macrophage J774 cell line as a positive control, RT-PCR, immunoblotting, and
immunolabelling established the presence of P2X7 in EOC13 cells. A cyto�uorometric assay demonstrated that the P2X7 agonists
adenosine-5� -triphosphate (ATP) and 2� (3� )-O-(4-benzoylbenzoyl) ATP induced ethidium+ or YO-PRO-12+ uptake into both cell
lines. ATP induced ethidium+ uptake into EOC13 cells in a concentration-dependent manner, with an EC50 of ∼130 𝜇𝜇M. e P2X7
antagonists Brilliant Blue G, A438079, AZ10606120, and AZ11645373 inhibited ATP-induced cation uptake into EOC13 cells by
75–100%. A cyto�uorometric assay demonstrated that P2X7 activation induced ROS formation in EOC13 cells, via a mechanism
independent of Ca2+ in�ux and K+ e�ux. Cyto�uorometric measurements of Annexin-V binding and 7AAD uptake demonstrated
that P2X7 activation induced EOC13 cell death. e ROS scavenger N-acetyl-L-cysteine impaired both P2X7-induced EOC13 ROS
formation and cell death, suggesting that ROS mediate P2X7-induced EOC13 death. In conclusion, P2X7 activation induces the
uptake of organic cations, ROS formation, and death in EOC13 microglia.

1. Introduction
Microglia are the resident innate immune cells of the central
nervous system (CNS) and play an important role in immune
surveillance [1] and in the pathogenesis and progression of
a number of CNS disorders [2]. Microglia are constantly
mobile, spending time scanning the extracellular space of
the CNS [1]. In response to brain injury or immunological
stimuli, these cells become activated and undergo dramatic
morphological and functional changes, which are highly
dependent on the context of their activation [3]. Activated
microglia phagocytose debris and peptides, present antigens,
and produce a number of soluble factors. ese factors may be
in�ammatory, regulatory, or cytotoxic in nature and include
reactive oxygen species (ROS), nitric oxide (NO), proin�ammatory and anti-in�ammatory cytokines, prostaglandins,
and growth factors [4, 5]. Microglia can be both neuroprotective or neurotoxic when activated, depending on the
factors they produce and the quantity and context in which

they are released, with prolonged or excessive activation
of these cells being associated with neuroin�ammation and
the progression of a number of CNS disorders [6]. e
mechanisms behind enhanced microglial activation in these
disorders and the features determining the balance between
neuroprotection and neurotoxicity are not fully understood.
e P2X7 receptor is a trimeric ligand-gated cation
channel belonging to the P2X family of purinergic receptors [7]. P2X7 is predominately expressed on mononuclear
leukocytes including macrophages and microglia and plays a
role in in�ammation and immunity [8]. In particular, P2X7
is currently receiving attention due to its possible roles in
neuroin�ammation [9]. Activation of P2X7 by extracellular
adenosine-5� -triphosphate (ATP), or the most potent P2X7
agonist, 2� (3� )-O-(4-benzoylbenzoyl) ATP (BzATP), causes
the passage of small cations including Ca2+ , Na+ , and K+
across the plasma membrane, as well as organic cations,
such as the �uorescent dyes ethidium+ and YO-PRO-12+ [7].
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Compared to other P2X receptors, P2X7 requires relatively
high ATP concentrations for activation, with a half maximal
eﬀective concentration (EC50 ) of 100–300 𝜇𝜇M [7]. Activation
of P2X7 leads to a number of cell-speci�c downstream signalling events, including the formation of ROS and reactive
nitrogen species [10], and either cell proliferation or death
[11, 12].
Using molecular, immunochemical, and pharmacological techniques, we demonstrate in the current study that the
murine microglial EOC13 cell line [13] expresses functional
P2X7. Activation of P2X7 by ATP in this cell line induces the
uptake of organic cations, ROS formation, and cell death.

2. Materials and Methods
2.1. Reagents and Antibodies. RPMI-1640 and DMEM/F12
media, GlutaMAX, normal horse serum (NHS), 0.05%
trypsin, YO-PRO-12+ , 2� ,7� -dichlorodihydro�uorescein diacetate (H2 DCFDA), and 2� ,7� -di�uoro�uorescein diacetate
(DAF-FM DA) were from Invitrogen (Grand Island, NY).
Fetal bovine serum (FBS) (heat-inactivated before use) was
from Bovogen Biologicals (East Keilor, Australia). ATP,
BzATP, ethidium bromide, dimethyl sulfoxide (DMSO),
glycerol gelatin, and the P2X7 antagonist Brilliant Blue
G (BBG) were from Sigma-Aldrich (St. Louis, MO). e
P2X7 antagonists A438079, AZ10606120, and AZ11645373
were from Tocris Bioscience (Ellisville, MO). Primers were
from GeneWorks (Hindmarsh, Australia). Protease inhibitor
cocktail tablets (complete, Mini, EDTA-free) and AnnexinV-Fluorescein were from Roche Diagnostics (Penzberg,
Germany). SuperSignal West Pico Chemiluminescent Substrate was from Pierce (Rockford, IL). e viability dye
7-aminoactinomycin D (7AAD) and the ROS scavenger
N-acetyl-L-cysteine (NAC) were from Enzo Life Sciences
(Plymouth Meeting, PA). e broad-spectrum ROS inhibitor
diphenyleneiodonium (DPI) was from Cayman Chemical
(Ann Arbor, MI). Phenyl-methyl-sulfonyl-�uoride (PMSF),
n-dodecyl 𝛽𝛽-D-maltoside, and ethylene glycol tetraacetic
acid (EGTA) were from Amresco (Solon, OH).
Cells preincubated with H2 O soluble compounds (BBG,
A438079, and AZ10606120) were compared to cells preincubated in the absence of each compound. Cells preincubated
with DMSO soluble compounds (AZ11645373 and DPI) were
compared to cells preincubated with DMSO alone. Solutions
containing 40 mM NAC were prepared in NaCl medium
(140 mM NaCl, 5 mM NaOH, 5 mM KCl, 10 mM HEPES, and
5 mM glucose, pH 7.4) and adjusted to pH 7.4; cells were
then preincubated in NaCl medium with or without NAC.
When studied, antagonists/inhibitors were present during
incubations with ATP.
Rabbit anti-mouse P2X7 (extracellular epitope) polyclonal antibody (Ab) and rabbit anti-rat P2X7 (C-termini
epitope) Ab (and corresponding blocking peptide) were from
Alomone Labs (Jerusalem, Israel). Peroxidase-conjugated
goat anti-rabbit IgG Ab was from Rockland Immunochemicals (Gilbertsville, PA). Cy3-conjugated donkey anti-rabbit
IgG Ab was from Jackson ImmunoResearch (West Grove,
PA). Rat anti-mouse P2X7 monoclonal antibody (mAb)
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(clone HANO43) was from Enzo Life Sciences. Rat IgG2b isotype control mAb and allophycocyanin- (APC-) conjugated
donkey anti-rat IgG Ab were from eBioscience (San Diego,
CA).
2.2. Cell Lines. e murine macrophage J774 cell line, the
murine microglial EOC13 cell line, and the murine lymphoblast LADMAC cell line, all originally obtained from
the American Type Culture Collection (Manassas, VA), were
kindly provided by Jasmyn Dunn (University of Queensland,
Brisbane, Australia) (J774) and Iain Campbell (University
of Sydney, Sydney, Australia) (EOC13 and LADMAC). J774
cells were maintained in RPMI-1640 medium containing
10% FBS and 2 mM GlutaMAX (complete RPMI medium).
EOC13 cells were maintained in DMEM/F12 supplemented
with 10% FBS, 2 mM GlutaMAX, and 20% LADMAC conditioned medium (complete DMEM medium). Cell lines were
maintained at 37∘ C and 95% air/5% CO2 and passaged every
3-4 days. Quarterly mycoplasma testing was carried out using
the MycoAlert Mycoplasma Detection Kit (Lonza, Rockland,
ME), as per the manufacturer’s instructions. For experiments,
cells were harvested by cell scraping unless otherwise stated.
2.3. Fluorescent Cation Dye Uptake Assay. Cells were washed
in NaCl medium (300 ×𝑔𝑔 for 5 min), resuspended in
NaCl medium, and equilibrated at 37∘ C for 5 min (1 ×
105 cells/1 mL/tube). Cells were then incubated with 25 𝜇𝜇M
ethidium+ (or 1 𝜇𝜇M YO-PRO-12+ where indicated) in the
absence or presence of the P2X7 agonists ATP or BzATP
(as indicated) for 5 min. In some experiments, ATP-induced
cation uptake was assessed with cells suspended in KCl
medium (150 mM KCl, 5 mM glucose, and 10 mM HEPES,
pH 7.4) or in NaCl medium containing 1 mM CaCl2 or
100 𝜇𝜇M EGTA. In other experiments, cells were preincubated
in the absence or presence of P2X7 antagonists or the ROS
scavenger NAC (as indicated) for 15 and 30 min, respectively, prior to cation and ATP addition. Incubations with
nucleotides were stopped by the addition of an equal volume
of ice-cold NaCl medium containing 20 mM MgCl2 (MgCl2
medium) followed by centrifugation (300 ×𝑔𝑔 for 5 min). Cells
were washed once with NaCl medium and events collected
using a LSR II �ow cytometer (BD Biosciences, San Diego,
CA) (excitation 488 nm, emission collected with 575/26 and
515/20 band-pass �lters for ethidium+ and YO-PRO-12+ ,
resp.). e mean �uorescence intensity (MFI) of relative
cation uptake was determined using FlowJo soware (Tree
Star, Ashland, OR).
2.4. P2X7 Expression by RT-PCR. Total RNA isolation from
cells was performed using the RNeasy Mini Kit (Qiagen,
Hilden, Germany) as per the manufacturer’s instructions.
PCR ampli�cation was performed as described previously
[14] using SuperScript III One-Step RT-PCR System Platinum Taq DNA polymerase (Invitrogen) with 500 ng of RNA,
and P2X7 forward (5� -ATATCCACTTCCCCGGCCAC-3� )
and reverse (5� -TCGGCAGTGATGGGACCAG-3� ) primers
for 42 cycles (94∘ C, 1 min; 68∘ C, 1 min; 72∘ C, 1 min). PCR
products were separated on a 2% agarose gel in Tris-acetate
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EDTA buﬀer and visualised with ethidium bromide staining.
Images of gels were collected using a Gel Logic 212 PRO
imaging system (Carestream Health, Rochester, NY).
2.5. P2X7 Protein Detection by Immunoblotting. Cells were
washed three times with phosphate-buﬀered saline (PBS)
(300 ×𝑔𝑔 for 5 min) and lysed (1 × 107 cells/mL) over
60 min in ice-cold lysis buﬀer (50 mM BisTris, 750 mM 6aminohexanoic acid, 1% n-dodecyl 𝛽𝛽-D-maltoside, 1 mM
PMSF, and protease inhibitor cocktail, pH 7.0). Cells were
sheared by passing ten times through a 21 G needle and
stored at −20∘ C until needed. Cells were then thawed and
cleared (16,000 ×𝑔𝑔 at 4∘ C for 10 min). Supernatants (25 𝜇𝜇g
protein/lane) were separated under reducing conditions
(5% 𝛽𝛽-mercaptoethanol) using a discontinuous SDS-PAGE
system with a 4% stacking gel and 10% separating gel.
Proteins were then transferred to nitrocellulose membranes
(Bio-Rad, Hercules, CA) and blocked at 4∘ C overnight with
Tris-buﬀered saline (250 mM NaCl and 50 mM Tris, pH 7.5)
containing 0.2% Tween-20 and 5% milk powder. e following day, nitrocellulose membranes were incubated at room
temperature for 2 h with anti-mouse P2X7 Ab (1 : 500) in
Tris-buﬀered saline containing 0.2% Tween-20 and 5% milk
powder. Membranes were washed three times over 30 min
with Tris-buﬀered saline containing 0.2% Tween-20 and
then incubated at room temperature for 1 h with peroxidiseconjugated anti-IgG Ab (1 : 1000) in Tris-buﬀered saline
containing 0.2% Tween-20 and 5% milk powder. Membranes
were washed as above and visualised using chemiluminescent
substrate and Amersham Hyper�lm ECL (GE Healthcare,
Little Chalfont, Buckinghamshire, �K). Images of �lms were
collected using a GS-800 Calibrated Densitometer (Bio-Rad).
2.6. Cell Surface P2X7 Protein Detection by Flow Cytometry.
Cells in NaCl medium containing 10% NHS and 0.02%
NaN3 (1 × 105 cells/200 𝜇𝜇L/tube) were incubated with antiP2X7 or rat IgG2b isotype control mAb (5 𝜇𝜇g/mL) at room
temperature for 30 min. Cells were then washed twice with
NaCl medium (300 ×𝑔𝑔 for 5 min) and incubated with APCconjugated anti-rat IgG Ab (1.3 𝜇𝜇g/mL) and 7AAD (to
exclude dead cells) for 30 min protected from light. Cells were
washed once as above. Events were then collected using a LSR
II �ow cytometer (excitation 633 nm, emission collected with
660/20 band-pass �lter for APC; excitation 488 nm, emission
collected with 695/40 band-pass �lter for 7AAD). Relative
cell-surface P2X7 was determined using FlowJo soware and
is expressed as the diﬀerence in the MFI of speci�c mAb
labelling and isotype control labelling.
2.7. P2X7 Protein Detection by Confocal Microscopy. EOC13
or J774 cells in their respective complete culture medium
were plated into 24-well plates with 13 mm glass coverslips (5
× 104 cells/0.5 mL/well) and incubated at 37∘ C, 95% air/5%
CO2 overnight to allow time to adhere. e following day,
cells were �xed with 4% paraformaldehyde in PBS at room
temperature for 15 min and then washed three times with
PBS over 10 min. Cells were incubated with permeabilisation solution (PBS containing 0.1% DMSO, 2% NHS, and
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0.1% Triton X-100) at room temperature for 10 min and
washed three times with PBS. Cells were then blocked with
20% NHS in PBS at room temperature for 20 min. Cells
were incubated at 4∘ C overnight with anti-rat P2X7 Ab
(5 𝜇𝜇g/mL; preincubated for 1 h in the absence or presence
of blocking peptide as per the manufacturer’s instruction)
in PBS containing 1% BSA, 0.2% NHS, and 0.05% NaN3 .
Cells were then washed as above and incubated at room
temperature for 1 h with Cy3-conjugated anti-rabbit IgG Ab
(15 𝜇𝜇g/mL) in PBS containing 0.2% NHS. Cells were washed
as above and then the coverslips mounted onto slides with
50% (v/v) glycerol gelatin in PBS. Coverslips were sealed
with nail varnish. Cells were visualised using a DM IBRE
inverted microscope and TCS SP confocal imaging system
(Leica, Mannheim, Germany) (excitation 488 nm, emission
collected at 560–600 nm). Images were captured using Leica
Confocal Soware.
2.8. ROS Formation Assay. EOC13 cells in complete DMEM
medium were plated into 24-well plates (5 × 104 cells/
0.5 mL/well) and incubated at 37∘ C, 95% air/5% CO2
overnight. Cells were then incubated with NaCl medium containing 10 𝜇𝜇M H2 DCFDA (0.5 mL/well) at 37∘ C, 95% air/5%
CO2 , protected from light for 30 min. e medium was
removed, and cells were further incubated in NaCl medium
(containing 1 mM CaCl2 ) in the absence or presence of 2 mM
ATP at 37∘ C, 95% air/5% CO2 for 15 min. Incubations were
stopped by the addition of an equal volume of ice-cold MgCl2
medium. Cells were harvested using 0.05% trypsin (5 min,
37∘ C) and were washed once with NaCl medium. Events
were collected using a LSR II �ow cytometer (excitation
488 nm, emission collected at 515/20 nm) and the MFI of
relative dichloro�uorescein (DCF) determined using FlowJo
soware.
In some experiments, ATP-induced ROS formation was
assessed in KCl medium, in NaCl medium in the absence
of 1 mM CaCl2 or presence of 100 𝜇𝜇M EGTA, or in complete DMEM medium in the absence or presence of 10 𝜇𝜇M
AZ10606120 (15 min preincubation, prior to ATP addition).
As free Ca2+ lowers the concentration of ATP4− [15], cells
incubated in the absence of 1 mM Ca2+ were incubated with
1.4 mM ATP to provide equimolar ATP4− concentrations
(575 𝜇𝜇M), as calculated using the Bound and Determined
Program [16]. In other experiments, cells were preincubated
in the absence or presence of AZ10606120, NAC, or DPI
(as indicated) for 15, 30, and 30 min, respectively, prior to
ATP addition. Cells prior to harvesting were also visualised
by diﬀerential interference contrast (DIC) imaging using an
Eclipse TE2000 inverted microscope (Nikon, Tokyo, Japan)
to examine cell morphology, and DIC images were captured
using Image-Pro AMS (Version 6.1) (Media Cybernetics,
Rockville, MD).
2.9. NO Formation Assay. EOC13 cells in complete DMEM
medium were plated into 24-well plates (5 × 104 cells/0.5 mL/
well) and incubated at 37∘ C, 95% air/5% CO2 overnight.
Cells were then incubated with NaCl medium containing
10 𝜇𝜇M DAF-FM DA (0.5 mL/well) at 37∘ C, 95% air/5% CO2 ,
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protected from light for 30 min. e medium was removed,
and the cells were washed once. Cells were then preincubated
with NaCl medium in the absence or presence of 10 𝜇𝜇M
AZ10606120 at 37∘ C, 95% air/5% CO2 for 15 min. Following
this, cells were further incubated in the absence or presence
of 1.4 mM ATP for 15 min. Incubations were stopped by
the addition of an equal volume of ice-cold MgCl2 medium.
Cells were harvested using 0.05% trypsin (5 min, 37∘ C) and
were washed once with NaCl medium. Events were collected
using a LSR II �ow cytometer (excitation 488 nm, emission
collected at 515/20 nm) and the MFI of relative benzotriazole
derivative determined using FlowJo soware.
2.10. Cell Death Assay. EOC13 cells in complete DMEM
medium were plated into 24-well plates (5 × 104 cells/0.5 mL/
well) and incubated at 37∘ C, 95% air/5% CO2 overnight. Cells
were then incubated with �lter sterile ATP (as indicated) at
37∘ C, 5% CO2 for 24 h. In some experiments, cells were preincubated in the absence or presence of 10 𝜇𝜇M AZ10606120
or 40 mM NAC for 15 or 30 min, respectively, prior to ATP
addition. In other experiments, cells were preincubated in
the absence or presence of 40 mM NAC for 90 min, with
2 mM ATP added in the �nal 15�60 min, and then the
medium replaced and cells incubated at 37∘ C, 95% air/5%
CO2 for a further 24 h. Following the 24 h incubations, cells
were harvested from wells using 0.05% trypsin (5 min, 37∘ C)
and washed once with Annexin-V binding medium (NaCl
medium containing 5 mM CaCl2 ). Cells were then incubated
with Annexin-V binding medium containing Annexin-VFluorescein and 7AAD at room temperature protected from
light for 15 min. Events were collected using a LSR II �ow
cytometer (excitation 488 nm, emission collected with 515/20
and 695/40 band-pass �lters for Annexin-V-Fluorescein and
7AAD, resp.) and the MFI of Annexin-V-Fluorescein and
7AAD determined using FlowJo soware. Quadrant markers were used to determine the percentage of AnnexinV+ /7AAD− , Annexin-V− /7AAD+ , and Annexin-V+ /7AAD+
cells. In some experiments, cells prior to harvesting were
visualised by DIC imaging to examine cell morphology, and
DIC images captured as outlined in Section 2.8.
2.11. Data Presentation and Statistical Analyses. Data is
presented as the mean ± SD. Diﬀerences between multiple
treatments were compared by ANOVA paired with Tukey’s
HSD posttest using Prism 5 for Windows (Version 5.04)
(GraphPad Soware, San Diego, CA), with diﬀerences considered signi�cant for 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃. Concentration response and
inhibition curves were �tted using Prism 5 and assuming a
variable slope, with normalised and nonnormalised response
curves, respectively, selected to obtain the best �t. Estimates
of EC50 values and half maximal inhibitory concentrations
(IC50 ) were obtained from individual �ts of these plots.

3. Results

3.1. P2X7 Antagonists Inhibit ATP-Induced Ethidium+ Uptake
into J774 Macrophage Cells in a Concentration-Dependent
Manner. e murine macrophage J774 cell line is well known
to express functional P2X7 [17]. Moreover, our group has
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demonstrated the presence of functional P2X7 in various cell
types using a �xed-time �uorescent cation uptake assay (e.g.,
[14, 18]). erefore, this technique was used to con�rm the
presence of P2X7 in J774 cells and to validate the use of this
cell line as a positive control. Incubation of J774 cells with
the P2X7 agonist ATP and the most potent P2X7 agonist
BzATP induced signi�cant ethidium+ uptake into these cells
compared to cells incubated in the absence of nucleotide
(Figure 1(a)). In addition, incubation of J774 cells with ATP
induced signi�cant YO-PRO-12+ uptake compared to cells
incubated in the absence of ATP (Figure 1(b)). However,
ATP-induced YO-PRO-12+ uptake was signi�cantly lower
than ATP-induced ethidium+ uptake (Figure 1(b)).
A number of highly speci�c P2X7 antagonists, including
A438079 [19], AZ10606120 [20], and AZ11645373 [21], have
recently become available. In addition, BBG is commonly
used as a P2X7 antagonist in vitro and in vivo (e.g., [22, 23]).
erefore, to determine the optimum concentrations of these
antagonists required to inhibit murine P2X7, J774 cells were
preincubated in the absence or presence of varying concentrations of BBG, A438079, AZ10606120, and AZ11645373
and the ATP-induced ethidium+ uptake assessed. Each antagonist impaired 1 mM ATP-induced ethidium+ uptake in a
concentration-dependent manner, with IC50 values of 1.8 ±
0.2, 7.9 ± 0.4, 1.0 ± 0.1, and 1.5 ± 0.1 𝜇𝜇M, respectively
(Figure 1(c)). AZ10606120 and A438079 completely inhibited ethidium+ uptake at respective concentrations of 10
and 100 𝜇𝜇M. In contrast, BBG and AZ11645373 were partial
antagonists at the ATP concentration used (1 mM).

3.2. EOC13 Microglial Cells Express P2X7. To determine
whether EOC13 microglial cells express P2X7, a series of
experiments using J774 cells as a positive control were
performed. Firstly, RNA was isolated from EOC13 and J774
cells and ampli�ed by RT-PCR using primers for P2X7.
Similar to J774 cells, EOC13 cells were found to express
P2X7 mRNA, as evident from the 230 base pair band
corresponding to the size of the predicted product (Figure
2(a)). e presence of total P2X7 protein was determined
by probing separated whole lysates of both cell lines with an
anti-P2X7 Ab. Immunoblotting revealed one major protein
band of 75 kDa for both EOC13 and J774 cells (Figure 2(b)),
corresponding to the predicted size of glycosylated P2X7.
Moreover, both cell lines were incubated with an anti-P2X7
mAb and the presence of cell-surface P2X7 determined by
�ow cytometry. Immunolabelling demonstrated cell-surface
P2X7 on both EOC13 and J774 cells, with MFIs of 13 ± 2
and 14 ± 4, respectively (𝑛𝑛 𝑛 𝑛) (Figure 2(c)). Finally, both
cell lines were stained with an anti-P2X7 Ab and analysed
by confocal microscopy. is similarly demonstrated the
presence of cell-surface P2X7, as well as intracellular P2X7,
with bright staining observed on all cells (Figure 2(d)).
Preincubation of the anti-P2X7 Ab with blocking peptide
completely abrogated the detection of P2X7 in both cell lines
(data not shown). Together, these results indicate that P2X7
is expressed in EOC13 cells.
3.3. EOC13 Microglial Cells Express Functional P2X7. To
determine whether P2X7 was functional in EOC13 cells,
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F 1: P2X7 antagonists inhibit ATP-induced ethidium+ uptake into J774 macrophage cells in a concentration-dependent manner. (a and
b) J774 cells in NaCl medium were incubated with (a and b) 25 𝜇𝜇M ethidium+ or (b) 1 𝜇𝜇M YO-PRO-12+ in the absence (basal) or presence
of (a and b) 1 mM ATP or (a) 0.1 mM BzATP at 37∘ C for 5 min. (c) Cells in NaCl medium were preincubated with Brilliant Blue G (BBG),
A438079, AZ10606120, and AZ11645373 (as indicated) at 37∘ C for 15 min. Ethidium+ (25 𝜇𝜇M) was then added, and cells were incubated in
the absence or presence of 1 mM ATP at 37∘ C for 5 min. (a–c) Incubations were stopped by the addition of MgCl2 medium and centrifugation.
Mean �uorescence intensity (MFI) of �uorescent cation uptake (pore formation) was determined by �ow cytometry. (a and b) Results shown
as means ± SD, 𝑛𝑛 𝑛 𝑛; ∗∗∗ 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃 compared to corresponding basal; ††† 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃 compared to corresponding ATP. (c) Curves presented as
a percentage of the maximal ATP-induced ethidium+ uptake and expressed as the mean ± SD, 𝑛𝑛 𝑛 𝑛-4.

the �xed-time ethidium+ uptake assay was performed. Both
ATP and BzATP were found to induce signi�cant ethidium+
uptake into EOC13 cells compared to cells incubated in
the absence of nucleotide (Figure 3(a)). Next, EOC13 cells
were incubated with increasing concentrations of ATP. ATP
induced ethidium+ uptake in a concentration-dependent
manner, with maximal uptake obtained at an ATP concentration of 1 mM and with an EC50 of 130 ± 30 𝜇𝜇M (Figure 3(b)).
Subsequent characterisations of P2X7 in EOC13 microglia
were performed using this maximal concentration of ATP
(1 mM).
To determine if the observed ATP-induced ethidium+
uptake into EOC13 cells was mediated by P2X7, cells were

preincubated in the absence or presence of P2X7 antagonists at inhibitory concentrations optimal for 1 mM ATPinduced ethidium+ uptake in J774 cells, as demonstrated
above (Figure 1(c)). Preincubation of EOC13 cells with
30 𝜇𝜇M BBG, 100 𝜇𝜇M A438079, 10 𝜇𝜇M AZ10606120, and
30 𝜇𝜇M AZ11645373 resulted in signi�cant impairment of
ATP-induced ethidium+ uptake by 75 ± 2, 90 ± 1, 100 ± 0,
and 99 ± 1%, respectively (Figure 3(c)). None of the P2X7
antagonists except AZ11645373 signi�cantly altered the basal
ethidium+ uptake into EOC13 cells. Again with the exception
of AZ11645373, which reduced the amount of gated viable
cells by ∼30%, cell viability (as assessed by forward and side
scatter) was similar between treatments (data not shown).
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F 2: EOC13 microglial cells express P2X7. (a) RNA from EOC13 and J774 cells was ampli�ed by R�-PCR using primers for P2X7. �ater
in place of RNA was included as a negative control in the PCR reaction. PCR products were separated and visualised with ethidium bromide
staining. (b) EOC13 and J774 cell lysates were separated by SDS-PAGE, transferred to nitrocellulose, and probed with an anti-P2X7 Ab. (c)
EOC13 and J774 cells were labelled with an anti-P2X7 (solid line) or isotype control (shaded) mAb and then with APC-conjugated anti-IgG
Ab and 7AAD (to exclude dead cells). Relative P2X7 expression (mean �uorescence intensity) was determined by �ow cytometry. (d) Fixed
and permeabilised EOC13 and J774 cells were labelled with an anti-P2X7 Ab and then with Cy3-conjugated anti-IgG Ab. P2X7 (top panels)
and phase contrast (bottom panels) images were assessed by confocal microscopy. Bars represent 10 𝜇𝜇m. (a–d) Results are representative of
2-3 experiments.
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F 3: EOC13 microglial cells express functional P2X7. (a and b) EOC13 cells in NaCl medium were incubated with 25 𝜇𝜇M ethidium+
in the absence (basal) or presence of (a) 1 mM ATP, 0.1 mM BzATP, or (b) varying concentrations of ATP (as indicated) at 37∘ C for 5 min. (c
and d) Cells in NaCl medium were preincubated in the absence (control) or presence of (c) 30 𝜇𝜇M Brilliant Blue G (BBG), 100 𝜇𝜇M A438079,
30 𝜇𝜇M AZ11645373, or (c and d) 10 𝜇𝜇M AZ10606120 at 37∘ C for 15 min. (c) Ethidium+ (25 𝜇𝜇M) or (d) YO-PRO-12+ (1 𝜇𝜇M) was then added,
and (c and d) cells were incubated in the absence (basal) or presence of 1 mM ATP at 37∘ C for 5 min. (a–d) Incubations were stopped by
the addition of MgCl2 medium and centrifugation. Mean �uorescence intensity (MFI) of �uorescent cation uptake (pore formation) was
determined by �ow cytometry. (a, c, and d) Results shown as means ± SD, 𝑛𝑛 𝑛 𝑛; ∗∗∗ 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃 compared to corresponding basal; ††† 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃
compared to corresponding ATP in the absence of antagonist. (b) Curve presented as a percentage of the maximal ATP-induced ethidium+
uptake and expressed as the mean ± SD, 𝑛𝑛 𝑛 𝑛.

To determine if P2X7 activation could induce the uptake
of a second organic cation into EOC13 cells, cells were preincubated in the absence or presence of AZ10606120, and ATPinduced YO-PRO-12+ uptake examined. Similar to ethidium+
uptake, 1 mM ATP induced signi�cant YO-PRO-12+ uptake
into EOC13 cells compared to cells incubated in the absence
of ATP (Figure 3(d)). Moreover, preincubation of cells with
10 𝜇𝜇M AZ10606120 resulted in complete inhibition of ATPinduced YO-PRO-12+ uptake (Figure 3(d)). Incubation with
AZ10606120 did not signi�cantly alter the basal YO-PRO-12+
uptake (Figure 3(d)). Furthermore, cell viability (as assessed
by forward and side scatter) was similar between treatments
(data not shown). Collectively, these results indicate that
P2X7 is functional in EOC13 cells.
3.4. P2X7 Activation Induces ROS Formation in EOC13
Microglial Cells. P2X7 activation has been reported to induce
ROS formation in a number of cell types, including primary
microglia [24, 25]. us, ATP-induced ROS formation in the
EOC13 cell line was investigated using the ROS sensitive
probe DCF. Cells loaded with H2 DCFDA (which is converted
to DCF inside cells) were incubated in the absence or presence of ATP, and the subsequent ROS formation analysed by
�ow cytometry. As extracellular Ca2+ has been reported to be
important for P2X7-induced ROS formation in a number of
cell types [24, 26, 27], assays were initially conducted in the

presence of 1 mM Ca2+ . However, due to the inhibitory action
of Ca2+ on P2X7 [15], assays were initially conducted with
2 mM ATP. Incubation with 2 mM ATP induced signi�cant
ROS formation in EOC13 cells compared to cells incubated
in the absence of ATP (MFI of ROS formation 16.3 ± 0.6
and 5.18 ± 0.06, resp., 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃, 𝑛𝑛 𝑛 𝑛). Furthermore,
preincubation of cells with 10 𝜇𝜇M AZ10606120 resulted in
complete inhibition of ATP-induced ROS formation (Figure
4(a)), indicating that this process is mediated by P2X7
activation. As for cation uptake (Figure 3), AZ10606120 did
not signi�cantly alter the basal ROS formation (Figure 4(a))
or cell viability (as assessed by forward and side scatter) (data
not shown).
P2X7 is a ligand-gated cation channel [7]; therefore the
possible roles for cation �uxes in P2X7-induced ROS formation were next investigated. P2X7-induced ROS formation
has been reported to be partially dependent on Ca2+ in�ux
in human promyelocytes [26] and rat submandibular gland
cells [27]. us, to determine if Ca2+ in�ux is required
for P2X7-mediated ROS formation in EOC13 cells, ATPinduced ROS formation in the absence and presence of Ca2+
was investigated. For this comparison, equivalent amounts of
ATP4− (575 𝜇𝜇M) were used by adding 1.4 or 2 mM ATP to
NaCl medium nominally free of Ca2+ or containing 1 mM
Ca2+ , respectively. ATP induced signi�cant ROS formation
in both the absence and presence of 1 mM Ca2+ compared
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F 4: P2X7 activation induces ROS formation in EOC13 microglial cells. (Le panels) Adherent DCF-loaded EOC13 cells or (right
panels) suspended EOC13 cells in (a) NaCl medium containing 1 mM Ca2+ (preincubated in the absence (control) or presence of 10 𝜇𝜇M
AZ10606120 at 37∘ C for 15 min), (b) NaCl medium in the absence (control) or presence of 1 mM Ca2+ , (c) NaCl medium in the absence
(control) or presence of 100 𝜇𝜇M EGTA, or (d) NaCl or KCl medium were (a–d) incubated in the absence (basal) or presence of 575 𝜇𝜇M ATP4−
(2 mM or 1.4 mM ATP as explained in Section 2.8) at 37∘ C for (le panels) 15 min or (right panels) 5 min in the presence of 25 𝜇𝜇M ethidium+ .
(a–d) Incubations were stopped by the addition of MgCl2 medium and centrifugation. Mean �uorescence intensities (MFI) of (le panels)
DCF (ROS formation) or (right panels) ethidium+ uptake (pore formation) were determined by �ow cytometry and results shown as means
± SD, 𝑛𝑛 𝑛 𝑛; ∗∗∗ 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃 or ∗∗ 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃 compared to corresponding basal; ††† 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃 compared to corresponding ATP.

to similarly treated cells in the absence of ATP (Figure
4(b)). Cells incubated in the absence of Ca2+ had significantly higher ATP-induced ROS formation compared to
those incubated in the presence of Ca2+ . In contrast, ATPinduced ethidium+ uptake (P2X7 function) was similar in
cells incubated in the absence or presence of Ca2+ (Figure
4(b)), indicating that the diﬀerences in ATP-induced ROS
formation were not due to altered P2X7 function.
NaCl medium may contain nominal amounts of Ca2+ .
us, to further exclude a role for Ca2+ in P2X7-mediated
ROS formation in EOC13 cells, ATP-induced ROS formation
was investigated in the absence and presence of the Ca2+
chelator EGTA. Incubation with 1.4 mM ATP induced signi�cant but similar amounts of ROS formation in both the
absence and presence of 100 𝜇𝜇M EGTA compared to similarly
treated cells in the absence of ATP (Figure 4(c)). Again, ATPinduced ethidium+ uptake was similar in cells incubated in
the absence or presence of EGTA (Figure 4(c)).
Finally, the role of K+ in P2X7-induced ROS formation
in EOC13 cells was investigated. Both ROS and K+ eﬄux
have been reported to be involved in interleukin-1𝛽𝛽 (IL-1𝛽𝛽)
release from monocytes, although whether these downstream
processes are linked is yet to be established [28]. us, to
determine if K+ eﬄux is involved in P2X7-mediated ROS
formation in EOC13 cells, ATP-induced ROS formation was
compared with cells in NaCl medium and KCl medium,
which prevents the loss of intracellular K+ . Incubation with

1.4 mM ATP induced signi�cant ROS formation in both
NaCl and KCl media, with similar levels of ROS formation in
both media (Figure 4(d)). Likewise, ATP-induced ethidium+
uptake was similar in NaCl and KCl media (Figure 4(d)),
indicating that the inability of high extracellular K+ to impair
ATP-induced ROS formation was not due to altered P2X7
function.
To con�rm that P2X7 activation induced ROS formation
in EOC13 microglia, DCF-loaded cells in NaCl medium were
preincubated in the absence or presence of the ROS scavenger
NAC, before incubation in the absence or presence of ATP.
As above (Figure 4), 1.4 mM ATP induced signi�cant ROS
formation (Figure 5(a)). Preincubation with 40 mM NAC
inhibited ATP-induced ROS formation by 73.7±0.3% (Figure
5(a)). Basal ROS formation (Figure 5(a)) and cell viability
(as assessed by forward and side scatter) (data not shown)
were similar between treatments. Preincubation of cells with
40 mM NAC inhibited ATP-induced ethidium+ uptake by
30 ± 2% (Figure 5(b)). us, the inhibitory eﬀect of NAC on
P2X7-induced ROS formation may be partially attributed to
inhibition of P2X7 itself. However, incubation with NAC and
ATP, but not either compound alone, reduced the amount of
gated viable cells by ∼40% in the ethidium+ uptake assay (as
assessed by forward and side scatter) (data not shown). is
suggests that the inhibitory action of NAC on ATP-induced
ethidium+ uptake may be a result of cytotoxicity in this assay.
To con�rm that NAC did not induce morphological
changes or cause cytotoxicity under the conditions used for
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F 5: e ROS scavenger NAC inhibits P2X7-induced ROS and pore formation in EOC13 microglial cells. (a and c) Adherent DCFloaded EOC13 cells or (b) suspended EOC13 cells in NaCl medium were preincubated in the absence (control) or presence of 40 mM NAC
at 37∘ C for 30 min and then in the absence (basal) or presence of 1.4 mM ATP for (a and c) 15 min or (b) 5 min in the presence of 25 𝜇𝜇M
ethidium+ . (a–c) Incubations were stopped by the addition of MgCl2 medium and (a and b) centrifugation. (a and b) Mean �uorescence
intensities (MFI) of (a) DCF (ROS formation) or (b) ethidium+ upta�e (pore formation) were determined by �ow cytometry and results
shown as means ± SD, 𝑛𝑛 𝑛 𝑛; ∗∗∗ 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃 compared to corresponding basal; ††† 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃 compared to corresponding ATP in the absence
of NAC. (c) DIC images of cell morphology were acquired by microscopy. Bars represent 20 𝜇𝜇m. Results are representative of 2 experiments.
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in EOC13 cells compared to cells incubated in the absence
of ATP (Figure 6). Furthermore, preincubation of cells with
10 𝜇𝜇M AZ10606120 inhibited ATP-induced NO formation by
82 ± 11% (Figure 6), indicating that this process is mediated
by P2X7 activation. Again, AZ10606120 did not signi�cantly
alter the basal NO formation (Figure 6) or cell viability (as
assessed by forward and side scatter) (data not shown).
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F 6: P2X7 activation induces NO formation in EOC13
microglial cells. Adherent DAF-FM DA-loaded EOC13 cells in NaCl
medium were preincubated in the absence (control) or presence
of 10 𝜇𝜇M AZ10606120 at 37∘ C for 15 min and then in the absence
(basal) or presence of 1.4 mM ATP for 15 min. Incubations were
stopped by the addition of MgCl2 medium and centrifugation. Mean
�uorescence intensities (MFI) of ben�otria�ole (NO formation)
were determined by �ow cytometry and results shown as means
± SD, 𝑛𝑛 𝑛 𝑛; ∗∗∗ 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃 compared to corresponding basal;
†††
𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃 compared to corresponding ATP.

the ROS assay, DIC images of adherent cells were acquired
following incubation in the absence or presence of ATP. Cells
incubated in the absence or presence of NAC (without ATP)
displayed discrete cell bodies with long, spindled shaped
processes (Figure 5(c)), as previously observed [13]. Cells
incubated in the absence or presence of NAC (with ATP)
also displayed discrete cell bodies, but with retracted and
branched processes (Figure 5(c)), typical of ATP causing
membrane changes [29]. erefore, in the ROS assay, EOC13
cell morphology was not altered by NAC when compared to
the corresponding treatment.
DCF-loaded cells were also preincubated in the absence
or presence of the broad-spectrum ROS inhibitor DPI and the
ATP-induced ROS formation investigated. However, a 30 min
preincubation with DPI at various concentrations (5–40 𝜇𝜇M)
led to high amounts of cell death (data not shown), and thus
this compound was not examined further.
To further verify that P2X7 activation induces the formation of reactive species in EOC13 cells, ATP-induced NO
formation was investigated using the NO sensitive probe
DAF-FM DA. Cells loaded with DAF-FM DA (which reacts
with NO to form a �uorescent ben�otria�ole) were preincubated in the absence or presence of AZ10606120, followed
by incubation in the absence or presence of ATP, and the
subsequent NO formation analysed by �ow cytometry. Incubation with 1.4 mM ATP induced signi�cant NO formation

3.5. P2X7 Activation Induces Cell Death in EOC13 Microglial
Cells. P2X7 activation results in the death of various cell
types [11, 12]. To determine whether ATP induces the death
of EOC13 microglia, cells in complete DMEM medium
were incubated in the absence or presence of ATP for 24 h,
and then the percentage of Annexin-V+ /7AAD− , AnnexinV− /7AAD+ , and Annexin-V+ /7AAD+ cells examined by
�ow cytometry (Figure 7(a)). Cell death is expressed as the
total of dying (Annexin-V+ /7AAD− ) and dead (AnnexinV− /7AAD+ and Annexin-V+ /7AAD+ ) cells. Incubation with
either 2 or 3 mM ATP but not 1 mM ATP resulted in
signi�cantly higher percentages of total cell death compared
to cells incubated in the absence of ATP (Figure 7(a)). Next,
to determine if the ATP-induced EOC13 death was mediated
by P2X7 activation, cells were preincubated in the absence or
presence of AZ10606120 and then incubated in the absence
or presence of ATP for 24 h. As above (Figure 7(a)), 2 mM
ATP induced signi�cant cell death, with higher percentages
of total cell death compared to cells incubated in the absence
of ATP (Figure 7(b)). Preincubation with 10 𝜇𝜇M AZ10606120
completely inhibited ATP-induced cell death (Figure 7(b)),
indicating that this process is mediated by P2X7 activation.
P2X7-induced death of murine RAW264.7 macrophages
is mediated by ROS formation [30]. erefore, a role for ROS
in P2X7-induced death of EOC13 microglia was investigated.
To con�rm that P2X7 induced ROS formation under conditions used to induce cell death, DCF-loaded EOC13 cells
in complete DMEM medium were incubated in the absence
or presence of ATP, and then subsequent ROS formation
determined by �ow cytometry. Similar to ATP-induced cell
death (Figure 7(a)), incubation with 2 or 3 but not 1 mM
ATP induced signi�cant ROS formation in EOC13 cells
compared to cells incubated in the absence of ATP (Figure
7(c)). e requirement for higher ATP concentrations to
induce cell death (Figure 7(a)) or ROS formation (Figure
7(c)) compared to pore formation (Figure 3(b)) is in line
with the inhibitory action of divalent cations [15], which are
present in the culture medium but not in the NaCl medium
used. To con�rm that this ROS formation was mediated by
P2X7, cells were preincubated with AZ10606120 and the
amounts of ATP-induced ROS formation determined. To
parallel the cell death experiments, 2 mM ATP was utilised.
Again, ATP induced signi�cant ROS formation compared
to cells incubated in the absence of ATP (Figure 7(d)).
Preincubation with 10 𝜇𝜇M AZ10606120 completely inhibited
this ATP-induced ROS formation (Figure 7(d)).
Finally, the eﬀect of NAC on P2X7-induced cell death was
investigated. EOC13 cells were preincubated in the absence
or presence of NAC followed by ATP for 24 h. However, 24 h
incubation with 40 mM NAC in the absence of ATP led to
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F 7: P2X7 activation induces cell death in EOC13 microglial cells. (a) Adherent EOC13 cells in complete DMEM medium were
incubated in the absence or presence of varying concentrations of ATP (as indicated) at 37∘ C for 24 h. (b) Adherent cells in complete DMEM
medium were preincubated in the absence or presence of 10 𝜇𝜇M AZ10606120 at 37∘ C for 15 min and then in the absence or presence of 2 mM
ATP for 24 h. (e and f) Adherent cells in complete DMEM medium were incubated in the absence or presence of 40 mM NAC at 37∘ C for
90 min and incubated in the absence or presence of 2 mM ATP for the �nal (e) 15–60 min or (f) 45 min (of the 90 min incubation), and then
the medium replaced with fresh complete DMEM medium for 24 h. (a, b, and e) Cells were harvested, labelled with Annexin-V-Fluorescein
and 7AAD, and the percentage of Annexin-V− /7AAD+ , Annexin-V+ /7AAD− , and Annexin-V+ /7AAD+ cells (together representing total cell
death) determined by �ow cytometry. (f) DIC images of cell morphology were acquired by microscopy. Bars represent 20 𝜇𝜇m. (c) Adherent
DCF-loaded cells in complete DMEM medium were incubated in the absence (basal) or presence of varying concentrations of ATP (as
indicated) at 37∘ C for 15 min. (d) Adherent DCF-loaded cells in complete DMEM medium were preincubated in the absence (control)
or presence of 10 𝜇𝜇M AZ10606120 at 37∘ C for 15 min and then in the absence (basal) or presence of 2 mM ATP for 15 min. (c and d)
Incubations were stopped by the addition of MgCl2 medium and centrifugation. Mean �uorescence intensity (MFI) of DCF (ROS formation)
was determined by �ow cytometry. Results shown as (a) dot plots of one representative set of data demonstrating the quadrant markers and
(a–e) means ± SD, 𝑛𝑛 𝑛 𝑛; ∗∗∗ 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃 or ∗ 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃 compared to (a and c) 0 mM ATP, (b and d) corresponding basal, or (e) corresponding
0 min ATP; ††† 𝑃𝑃 𝑃 𝑃𝑃𝑃𝑃𝑃 compared to corresponding ATP in the absence of (b and d) AZ10606120 or (e) NAC.

signi�cant amounts of EOC13 cell death (data not shown).
erefore, to reduce the total exposure to 40 mM NAC, cells
were incubated in the absence or presence of NAC for 90 min,
with ATP added in the �nal 15–60 min. e medium was
then replaced with fresh complete DMEM medium and the
cells incubated for 24 h. Incubation with 2 mM ATP for 30
or 60 min but not 15 min resulted in signi�cant cell death
compared to cells incubated in the absence of ATP (Figure
7(e)). In contrast to the 24 h incubation with NAC, 90 min
incubation with 40 mM NAC (without ATP) did not induce
signi�cant cell death compared to cells incubated for the same
length of time in the absence of both NAC and ATP (Figure
7(e)). A 60 min preincubation with NAC inhibited cell death
induced by 30 min incubation with ATP by 99 ± 6% (Figure
7(e)). In contrast, a 75 and 30 min preincubation with NAC,
followed by 15 and 60 min ATP treatment, respectively, had
no eﬀect on the percentage of cell death compared to cells
incubated for the same time length with ATP in the absence
of NAC (Figure 7(e)).
To further con�rm that NAC did not induce morphological changes or cause cytotoxicity under the conditions
used for the cell death assay, DIC images of adherent cells
were acquired following the 24 h incubation. As above (Figure
5(c)), cells incubated in the absence or presence of NAC
(without ATP) displayed discrete cell bodies with long,
spindled shaped processes (Figure 7(f)). In addition, cells
incubated in the presence of NAC and ATP displayed a
similar morphology to that of cells incubated in the absence
of ATP (Figure 7(f)). In contrast, cells preincubated with ATP
alone displayed rounded and granular cell bodies with no
or few processes (Figure 7(f)), characteristic of cell death.

Furthermore, wells preincubated with ATP alone had a
high amount of nonadherent cells compared to the other
treatments (data not shown). us, preincubation with NAC
prevented the morphological changes associated with ATP
incubation, but NAC alone had no eﬀect on cell morphology.

4. Discussion
e current study demonstrates for the �rst time that the
murine microglial EOC13 cell line expresses functional
P2X7. Firstly, the presence of P2X7 mRNA and protein
was established using RT-PCR and immunoblotting techniques. In addition, the presence of cell-surface P2X7 was
demonstrated using immuno�uorescence staining. Moreover, P2X7 on EOC13 microglia was functional, as the P2X7
agonists ATP and B�ATP induced signi�cant ethidium+ or
YO-PRO-12+ uptake into these cells. In these experiments,
ATP induced ethidium+ uptake with an EC50 value which
falls within the typical range for ATP-induced cation �uxes
mediated by recombinant murine P2X7 [31]. Furthermore,
pretreatment of cells with P2X7 antagonists inhibited ATPinduced organic cation uptake. Lastly, ATP could induce ROS
formation in and the death of EOC13 cells, and both of these
events, which are oen associated with P2X7 activation [10–
12], could be inhibited by the P2X7 antagonist AZ10606120.
e presence of functional P2X7 on EOC13 microglia is
consistent with the presence of this receptor on primary
microglia and microglial cell lines (including N9, N13, BV2, and NTW8 cells) [32–35].
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P2X7 activation induced ROS formation in EOC13
microglia. P2X7-induced ROS formation has been reported
in primary microglia [24, 25], and a role for this process
in microglia has been highlighted by several studies. P2X7
activation induces the production of the ROS, superoxide,
in primary rat microglia, while this receptor is upregulated in a transgenic mouse model of Alzheimer’s disease
[25]. Although a direct link between P2X7, superoxide,
and Alzheimer’s disease was not established, the authors
proposed a link between these molecules and this disease.
is link is supported by subsequent observations by others, where �brillar 𝛽𝛽-amyloid peptide, which is associated
with Alzheimer’s disease, caused ATP release and autocrine
activation of P2X7 leading to ROS formation in primary rat
microglia [24]. In addition, another group demonstrated that
P2X7-induced superoxide release from primary rat microglia
induced injury of rat cortical neurons [36]. Collectively,
this data indicates that P2X7-induced ROS formation from
microglia may be involved in various neuroin�ammatory
and neurodegenerative disorders. is may be of particular
importance in diseases where microglial P2X7 is reported
to be upregulated such as in Alzheimer’s disease, multiple
sclerosis, and amyotrophic lateral sclerosis [25, 37]. It should
be noted, however, that DCF, as employed in the current
study and as widely used by others to detect ROS, can also
propagate ROS formation [38]. Nevertheless, our observation
that P2X7 activation also induces the formation of NO in
EOC13 cells supports a role for this receptor in the formation
of reactive species.
e current study excluded an essential role for Ca2+
in�ux in P2X7-induced ROS formation in EOC13 microglia.
is �nding is similar to other observations with other
murine cell types, including submandibular glands [39] and
erythroid cells [40]. In contrast, P2X7-induced ROS formation in primary rat microglia [24] and rat submandibular
glands [27] is dependent on an in�ux of Ca2+ . e reason for
this diﬀerence between these two species remains unknown
but may re�ect diﬀerences in experimental protocols or
diﬀerences in signalling molecules between mice and rats.
e current study also excluded an essential role for K+
eﬄux in P2X7-induced ROS formation in EOC13 microglia.
Both ROS formation and K+ eﬄux are involved in IL-1𝛽𝛽
release from monocytes, although whether these downstream
processes are linked has not been established [28]. us, our
results indicate that P2X7-induced ROS formation does not
require K+ eﬄux and that ROS formation and K+ eﬄux may
be independent events in IL-1𝛽𝛽 release from myeloid cells.
P2X7 activation also induced cell death in EOC13
microglia. Use of an Annexin-V/7AAD assay suggested that
this process was mediated by apoptosis. However, in the
absence of other markers of apoptosis and necrosis, this
remains to be established, especially since P2X7 activation
induces both apoptosis and necrosis in the microglial N13
cell line [41]. Nevertheless, our observations support previous studies in which P2X7 activation induced death in
primary microglia and other microglial cell lines [41, 42].
e physiological role of P2X7-induced microglia death is
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unclear. Further obscuring this is the known role of P2X7
activation in inducing the proliferation of microglia [43]. is
paradoxical role of P2X7 is thought to be related to the relative
ATP concentration, with high concentrations promoting cell
death and low concentrations promoting cell proliferation
[44]. In support of this, our study observed that ATP only
induced EOC13 cell death at 2 or 3 but not 1 mM ATP.
Moreover, our data also showed that a transient incubation
with ATP of 30–60 but not 15 min induced cell death in
EOC13 microglia. is suggests that transient ATP release
and subsequent P2X7 activation may be suﬃcient to kill
microglia in vivo.
e current study examined a potential link between
P2X7-induced ROS formation and death in EOC13
microglia. A previous study demonstrated that the ATPinduced death of murine RAW264.7 macrophages was
mediated by ROS derived from NADPH oxidase downstream
of P2X7 activation [30]. is contrasts with another study,
which found that P2X7-induced ROS formation, but
not death, was attenuated in primary macrophages from
NADPH oxidase de�cient mice [45]. Our data using the
ROS scavenger NAC supports a role for ROS formation in
the P2X7-induced death of EOC13 microglia. e capacity
of NAC to prevent P2X7-induced EOC13 microglia death
was dependent on the preincubation time with NAC, as well
as the total incubation time with ATP, with only 45–60 min
preincubations with NAC preventing cell death induced by
transient 30–45 min exposures to ATP. In contrast, 24 h
incubation with NAC induced signi�cant amounts of EOC13
microglia death, equivalent to that induced by ATP alone.
is cytotoxicity of NAC may have occurred due to increased
toxic metabolic byproducts such as reduced glutathione [46].
Alternatively, scavenging of ROS by NAC may indicate
that low amounts of ROS are important for EOC13 cell
homeostasis. Of note, the ROS inhibitor DPI also induced
the death of EOC13 microglia, albeit over a much faster
time course. Finally, it should be noted that NAC inhibition
of P2X7-induced death and ROS formation in EOC13
microglia may have been partly due to direct inhibition of
P2X7. NAC inhibited ATP-induced pore formation by 30%
compared to a 74 and 99% inhibition of ATP-induced ROS
formation and cell death, respectively. is direct inhibition
of P2X7 by NAC was not due to an acidic pH, which is
known to impair P2X7 function [47], as the NAC-containing
solutions were adjusted to pH 7.4 before each assay. us,
our results indicate that either cellular signalling involving
ROS may modulate P2X7 activation in EOC13 microglia
or that NAC may directly impair P2X7 at 40 mM. e
concentration of NAC used in these experiments (40 mM) is
4–8-fold higher than that used in a number of similar studies
(e.g., [48]). e requirement for this high concentration of
NAC remains unknown but may re�ect a reduced ability of
NAC to cross the plasma membrane or to be converted to
glutathione in EOC13 cells.
e presence of functional P2X7 on J774 macrophage
cells was con�rmed in the current study. P2X7 is present in
this cell line [17], and activation of P2X7 leads to the release
of mature IL-1𝛽𝛽 [49], the formation of macrophage-derived
multinucleated giant cells [50–52], and cell death [53]. In this
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study, the potency of four P2X7 antagonists against 1 mM
ATP, the ATP concentration most commonly used to study
P2X7, was determined. e IC50 values for BBG, A438079,
and AZ11645373 (1.8, 7.9, and 1.5 𝜇𝜇M, resp.) were within one
log range of those published for recombinant murine P2X7
[54, 55]. In contrast, the IC50 value for AZ10606120 has not
been reported for murine P2X7, although this compound has
been shown to speci�cally bind to and inhibit rat and human
P2X7 [20]. In the current study, this highly speci�c P2X7
antagonist also completely impaired ATP-induced ethidium+
uptake, ROS formation, and death of murine EOC13 cells.
us, AZ10606120 will be useful for future studies of murine
P2X7.
In the CNS, extracellular ATP acting through P2X7 on
microglia is an important mediator of neuroin�ammation
[9]. ATP acts as a neurotransmitter and is released from
neurons during synaptic transmission and from dying cells
[56]. Under normal physiological conditions, extracellular
ATP concentrations in the CNS are estimated to be in the
nanomolar to micromolar range, depending on the balance
between ATP release and degradation, while intracellular
microglial ATP concentrations are in the millimolar range
[57]. Aer CNS injury, however, extracellular ATP concentrations increase and can reach as high as the millimolar
range [57]. Furthermore, it is hypothesised that ATP may
act on microglial P2X7 at very close range where the concentration of ATP may be quite high. Activation of P2X7 on
primary microglia and microglial cell lines leads to the release
of proin�ammatory IL-1𝛽𝛽 and tumour necrosis factor-𝛼𝛼
[33, 58] and ROS formation [24]. Although proin�ammatory factors are important for immunity [1], prolonged
or inappropriate release of such factors from chronically
activated microglial can be highly toxic to neurons and
can promote neuroin�ammation and neurodegeneration [5].
ere are a number of diseases in the CNS characterised by
the presence of activated microglia, including Alzheimer’s
disease, prion infection, cerebral ischemia, multiple sclerosis,
and amyotrophic lateral sclerosis. In such diseases, P2X7
has also been reported to be upregulated [25, 37, 59, 60].
is raises questions of possible roles for P2X7 in mediating
inappropriate microglial responses in CNS disorders.

5. Conclusions
is study demonstrates that EOC13 microglial cells express
functional P2X7. Activation of this receptor by ATP resulted
in organic cation uptake, ROS formation, and death in
these cells. Moreover, the EOC13 cell line may be useful
for investigating P2X7-mediated events in microglia and the
role of this receptor in microglia-mediated in�ammatory
disorders.
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